StonvexLoading…
StonvexStonvexStonvexCore line items from LVS's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Annual 2025 2025-09-30 | Annual 2025 2025-06-30 |
|---|---|---|---|---|
Revenue | $3.58B | $13.02B | $3.33B | $3.17B |
Operating Income | $904.00M | $2.82B | $719.00M | $783.00M |
Net Income | $567.00M | $1.63B | $419.00M | $461.00M |
EPS (Diluted) | $0.85 | $2.35 | $0.61 | $0.66 |
Total Assets | $21.18B | $21.92B | $21.50B | $21.85B |
Total Liabilities | $19.57B | $19.99B | $19.64B | $19.57B |
Cash & Equivalents | $3.33B | $3.84B | $3.35B | $3.45B |
Free Cash Flow OCF − CapEx | $537.00M | $1.85B | $925.00M | $39.00M |
Shares Outstanding | 663.00M | 675.00M | 678.00M | 687.00M |